Page last updated: 2024-11-03

rimantadine and Papillomavirus Infections

rimantadine has been researched along with Papillomavirus Infections in 2 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Papillomavirus Infections: Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Miyauchi, S1
Sanders, PD1
Guram, K1
Kim, SS1
Paolini, F1
Venuti, A1
Cohen, EEW1
Gutkind, JS1
Califano, JA1
Sharabi, AB1
Wetherill, LF1
Wasson, CW1
Swinscoe, G1
Kealy, D1
Foster, R1
Griffin, S1
Macdonald, A1

Other Studies

2 other studies available for rimantadine and Papillomavirus Infections

ArticleYear
HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.
    Cancer research, 2020, 02-15, Volume: 80, Issue:4

    Topics: Adolescent; Adult; Aged; Animals; Antigen Presentation; Antineoplastic Agents, Immunological; Antine

2020
Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5.
    Antiviral research, 2018, Volume: 158

    Topics: Antiviral Agents; Cell Line; Cyclin B1; Humans; Imino Sugars; Ion Channels; Keratinocytes; MAP Kinas

2018